Surgical treatment of biliary ductal stricture complicating localized left hepatolithiasis

Sun, Wenbing; Han, Bing; Cai, Jin; He, Zhenping

doi:10.3748/wjg.v3.i1.24

Cited by 1 publication

(1 citation statement)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There are no data yet on complications of short FCSEMS use for each condition for various BBSs other than LDLT. Comprehensive BBS studies, including those caused by LDLT, provide migration complication rates of 10% to 16% for conventional FCSEMSs, but the migration complication rate in this study was 4%, demonstrating the effectiveness of the waist shape that narrows the center of the stent to prevent migration [ 24 , 25 , 26 , 27 ]. Additionally, the presence of radiopaque markers in the center and at both ends of the stent facilitates proper positioning [ 15 ].…”

Section: Discussionmentioning

confidence: 90%

A Short Fully Covered Self-Expandable Metal Stent for Management of Benign Biliary Stricture Not Caused by Living-Donor Liver Transplantation

Lee,

Jang,

Chung

et al. 2024

JCM

View full text Add to dashboard Cite

Background: This study evaluated the effectiveness of short fully covered self-expanding metal stents (FCSEMS) with an anti-migration design in treating benign biliary strictures (BBS) not related to living donor liver transplantation (LDLT). Methods: A retrospective analysis was conducted on 75 patients who underwent FCSEMS insertion for BBS management. Stents were initially kept for 3 months and exchanged every 3 months until stricture resolution. Adverse events and stricture recurrence after FCSEMS removal were assessed during follow-up. Results: The study outcomes were technical success, stenosis resolution, and treatment failure. Technical success was 100%, with stricture resolution in 99% of patients. The mean onset time of BBS post-surgery was 4.4 years, with an average stent indwelling period of 5.5 months. Stricture recurrence occurred in 20% of patients, mostly approximately 18.8 months after stent removal. Early cholangitis and stent migration were noted in 3% and 4% of patients, respectively. Conclusions: This study concludes that short FCSEMS demonstrate high efficacy in the treatment of non-LDLT-related BBS, with a low incidence of interventions and complications. Although this is a single-center, retrospective study with a limited sample size, the findings provide preliminary evidence supporting the use of short FCSEMS as a primary treatment modality for BBS. To substantiate these findings, further research involving multicenter studies is recommended to provide additional validation and a broader perspective.

show abstract